No profile data available.
Whan In Pharm Co.,Ltd. (016580.KS) is a healthcare company in the brain and nerve treatment drugs industry, based in Seoul, South Korea, with about 631 full-time employees.
It reported revenue of 255.21 billion KRW for fiscal year 2025, down 1.7% from fiscal year 2024, and net income of 13.60 billion KRW. In Q1 2026 (the quarter ended March 31, 2026) revenue was 71.18 billion KRW, up 18.2% from a year before. Its market capitalization was 188.17 billion KRW as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 8, 2026.
,Ltd. manufactures and sells various pharmaceutical products in South Korea.
Whan In Pharm reported 255.21 billion KRW in revenue for fiscal year 2025, down 1.7% from 259.60 billion KRW in fiscal year 2024. In Q1 2026 revenue was 71.18 billion KRW.
188.17 billion KRW as of October 8, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include SK Biopharmaceuticals Co., Ltd. (326030.KS), Korean Drug Co., Ltd. (014570.KQ), Shaperon Inc. (378800.KQ).